1 |
high-grade serous ovarian cancer
(731 times)
|
Neoplasms (389 times)
|
OS (57 times) PFS (52 times) HR (46 times)
|
2010 Is low-grade serous ovarian cancer part of the tumor spectrum of hereditary breast and ovarian cancer?
|
2 |
high-grade serous OC
(9 times)
|
Neoplasms (7 times)
|
OC (6 times) EOC (3 times) BFDP (1 time)
|
2015 Overexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells.
|
3 |
high-grade serous carcinoma
(8 times)
|
Neoplasms (6 times)
|
CL (1 time) CNVs (1 time) CPT1A (1 time)
|
2016 Ovarian low and high grade serous carcinomas: hidden divergent features in the tumor microenvironment.
|
4 |
high-grade serous epithelial ovarian cancer
(8 times)
|
Neoplasms (4 times)
|
LVSI (2 times) OS (2 times) EOC (1 time)
|
2013 Evidence for the antagonistic form of CXC-motif chemokine CXCL10 in serous epithelial ovarian tumours.
|
5 |
high grade serous ovarian cancer patients
(1 time)
|
Neoplasms (1 time)
|
---
|
2019 Adaptive responses in a PARP inhibitor window of opportunity trial illustrate limited functional interlesional heterogeneity and potential combination therapy options.
|
6 |
high grade SOC
(1 time)
|
Biochemistry (1 time)
|
FIGO (1 time) FZD2 (1 time) p-STAT3 (1 time)
|
2019 ALPL regulates the aggressive potential of high grade serous ovarian cancer cells via a non-canonical WNT pathway.
|
7 |
high-grade serous adenocarcinoma of ovary
(1 time)
|
Hematology (1 time)
|
CSCs (1 time) PMCs (1 time)
|
2019 Cancer stem cells contribute to angiogenesis and lymphangiogenesis in serous adenocarcinoma of the ovary.
|
8 |
high-grade serous carcinomas
(1 time)
|
Neoplasms (1 time)
|
OC (1 time) OS (1 time) TIC (1 time)
|
2022 High ratio of pCXCR4/CXCR4 tumor infiltrating immune cells in primary high grade ovarian cancer is indicative for response to chemotherapy.
|
9 |
high-grade serous subtype of epithelial ovarian carcinoma
(1 time)
|
Neoplasms (1 time)
|
Dicer-Pten DKO (1 time)
|
2016 Epithelialization of mouse ovarian tumor cells originating in the fallopian tube stroma.
|